Lexicon Pharmaceuticals | Creditori Commerciali

Prezzo Delle Azioni
1.31
Cambio Giornaliero
-0.01 -0.38%
Mensile
10.59%
Annuale
87.77%
Q1 Previsione
2.01




Creditori Commerciali Cambiamento Data
Abbott USD 4.12B 183M 2025-09
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Agios Pharmaceuticals USD 19.55M 2.02M 2025-09
Akebia Therapeutics USD 10.09M 1.47M 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
AstraZeneca USD 25.28B 252M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Coherus Biosciences USD 24.89M 12.73M 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Halozyme Therapeutics USD 15.36M 3.33M 2025-09
Illumina USD 240M 22M 2025-12
Insmed USD 79.59M 1.24M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
J&J USD 9.62B 161M 2025-09
Lexicon Pharmaceuticals USD 5.9M 4.79M 2025-06
MacroGenics USD 5.94M 1.28M 2025-09
MannKind USD 7.27M 2.99M 2025-09
Merck USD 4.15B 102M 2025-09
Moderna USD 267M 92M 2025-09
Novartis USD 4.56B 49M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Thermo Fisher Scientific USD 3.12B 140M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 468M 36M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12


Lexicon Pharmaceuticals Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.